Business Year 2007
We were expecting a successful 2007 and we were right. The significant increase in turnover, the investments in R&D and the international expansion of production locations are the consistent continuation of our strategy; the aim of which is to increase market shares and develop new, innovative product solutions.
Turnover und Cash Flow: 2004 - 2007 in Mill. €
| 2004 | 2005 | 2006 | 2007 | |
|---|---|---|---|---|
| Turnover cons. | 184.5 | 203.6 | 219.6 | 241.8 |
| Cash Flow | 18.3 | 23.6 | 19.6 | 29.5 |
Turnover Increase For 2007
The two business divisions Preanalytics and BioScience achieved a total growth of 11% in 2007, whereby the Preanalytics sector increased turnover by 12.3% The BioScience sector grew by 8.4%. The total turnover increased from € 219,6 million to € 241.8 million. The total of Greiner Bio-One employees has also increased slightly to 1250.
High quality microplates for pharmaceutical research were the main contribution to the BioScience turnover. In the area of Preanalytics, standard products as well as safety products for blood collection brought above average growth.
The OEM business with well-known companies has also been expanded.
Based on the full production capacity and high number of orders for the months of January, February and March, we are very optimistic for the coming year.